The credit facility is aimed at financing the company’s working capital and assets financing
Middle East Pharmaceutical Industries Co. (Avalon Pharma) renewed a Shariah-compliant credit facility agreement with the Saudi Investment Bank (SAIB) at a value of SAR 54.23 million. 
In a statement to Tadawul, the company said that the credit facility, whose tenor is one year, is aimed to finance its working capital and assets financing.
For more news on listed companies
It added that the facility is guaranteed by a promissory note for an amount of SAR 54.23 million.
The credit facility is aimed at financing the company’s working capital and assets financing
Middle East Pharmaceutical Industries Co. (Avalon Pharma) renewed a Shariah-compliant credit facility agreement with the Saudi Investment Bank (SAIB) at a value of SAR 54.23 million.
In a statement to Tadawul, the company said that the credit facility, whose tenor is one year, is aimed to finance its working capital and assets financing.
For more news on listed companies
It added that the facility is guaranteed by a promissory note for an amount of SAR 54.23 million.
